On April 27, the Shanghai Stock Exchange issued a notice regarding adjustments to the list of eligible securities under the Shanghai-Hong Kong Stock Connect program. MABWELL-B (02493), the H-share listing of Shanghai-listed Mabwell(Shanghai)Bioscience Co.,Ltd. (688062), has been included in the program. The inclusion follows the company's H-share listing on the Hong Kong Stock Exchange, which is not subject to a price stabilization mechanism, and the completion of 10 trading days for its corresponding A-shares. According to the relevant provisions of the Shanghai-Hong Kong Stock Connect implementation rules, the adjustment to the list of eligible港股通 securities takes effect from the next trading day of the program.
Comments